Adendra Therapeutics
London
About Adendra Therapeutics
Adendra is an emerging biotechnology company building on new insights into dendritic cell biology to discover and develop new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $53.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: adendratx.com
Industries & Categories
Biopharma, Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/adendra-therapeutics-53448 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.